Sign in
Use of Anti – VEGF Therapy for ROP: When and How
Updates from the Field
2017
Persistent Tunica Vasculosa Lentis as an Independent Risk Factor for Treatment in Retinopathy of Prematurity
Nimesh A. Patel, MD
Annual Meeting Talks
2020
Economic Impact of the Use of Anti-VEGF Monotherapy or in Combination With Panretinal Photocoagulation in the Treatment of Retinopathy of Prematurity
Swati Agarwal-Sinha, MD, FASRS
2019
Category: Pediatric Retina